
Medios AG
MEDOF
Updated: 23/09/2026, 02:38:44
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
No summaries found.
- Share price
- $50.00
- Market cap
- $1.28B
- Exchange
- OTC
- Currency
- USD
- CEO
- Thomas Meier
- Employees
- 993
- IPO date
- 10/11/2021
- Beta
- 1.296
- Last dividend
- $0.00
- Day range
- $13.64 – $50.00
- 52-week range
- $13.64 – $50.00
- 1-day performance
- 0.00%
- 1-year performance
- 266.57%
- Current drawdown (1Y)
- 0.00%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- DE000A1MMCC8
- Created
- 07/12/2025, 05:12:58
- Last update
- 23/09/2026, 02:38:44
Track Medios AG with an AI analyst
See which prediction-market events move MEDOF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.